Red blood cell exchange to avoid intubating a COVID‐19 positive patient with sickle cell disease?

As the COVID‐19 pandemic continues to claim lives across the globe, insufficient data exists regarding the optimal treatment. It is well known that patients 55 years of age or older and patients with certain chronic diseases are at higher risk of severe illness, including acute respiratory distress...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical apheresis Vol. 35; no. 4; pp. 378 - 381
Main Authors Allison, David, Campbell‐Lee, Sally, Crane, Jason, Vidanovic, Vladimir, Webb, Shaun, Fraidenburg, Dustin, Hussain, Faiz
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.08.2020
Wiley Subscription Services, Inc
Subjects
acute chest syndrome
Acute Chest Syndrome - etiology
Acute Chest Syndrome - therapy
Adult
Analgesics - therapeutic use
Anemia, Sickle Cell - complications
Antiviral Agents - therapeutic use
Azithromycin - therapeutic use
Betacoronavirus
Case Report
Combined Modality Therapy
Contraindications, Procedure
Coronavirus Infections - complications
Coronavirus Infections - drug therapy
COVID-19
Erythrocyte Transfusion - methods
Erythrocytes
HbSC
Hematology
Humans
Hydroxychloroquine - therapeutic use
Intubation, Intratracheal
Male
Methylprednisolone - therapeutic use
Oxygen Inhalation Therapy
Pandemics
Pneumonia, Viral - complications
Pneumonia, Viral - drug therapy
Respiration, Artificial
Respiratory Insufficiency - etiology
Respiratory Insufficiency - therapy
SARS-CoV-2
Sickle cell disease
HbSC
acute chest syndrome
SARS-CoV-2
Online AccessGet full text

Cover

More Information
Summary:As the COVID‐19 pandemic continues to claim lives across the globe, insufficient data exists regarding the optimal treatment. It is well known that patients 55 years of age or older and patients with certain chronic diseases are at higher risk of severe illness, including acute respiratory distress syndrome and death. A potentially fatal pulmonary complication of sickle cell disease, acute chest syndrome, can be precipitated by acute infections, including respiratory viruses. We report the case of a patient with sickle cell disease (HbSC) who developed COVID‐19 pneumonia and acute chest syndrome who was treated with emergent red blood cell exchange in order to avoid endotracheal intubation.
ISSN:0733-2459
1098-1101
DOI:10.1002/jca.21809